Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shaoxing Zhu"'
Autor:
Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li, Dingwei Ye
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 12, Pp 1047-1059 (2023)
Objective: Real-word data on long-acting luteinizing hormone-releasing hormone (LHRH) agonists in Chinese patients with prostate cancer are limited. This study aimed to determine the real-world effectiveness and safety of the LHRH agonist, goserelin,
Externí odkaz:
https://doaj.org/article/740ba6f7e2c940af8ffebb36db2754d7
IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
Autor:
Yipeng Xu, Gabriela Pachnikova, He Wang, Yaoyao Wu, Dorothea Przybilla, Reinhold Schäfer, Zihao Chen, Shaoxing Zhu, Ulrich Keilholz
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 4 (2022)
Preclinical models of tumors have the potential to become valuable tools for commercial drug research and development, and 3D culture systems are gaining traction in this area, particularly in prostate cancer (PCa) research. However, nearly all 3D dr
Externí odkaz:
https://doaj.org/article/55af9b551abd4e14a0e501ec883fd077
Autor:
SHAOXING ZHU1, YIPENG XU1 xuyp1631@zjcc.org.cn, MEI SONG2, GUIPING CHEN1, HUA WANG1, YANG ZHAO1, ZONGPING WANG1, FANGYIN LI1
Publikováno v:
Molecular Medicine Reports. Oct2016, Vol. 14 Issue 4, p3357-3361. 5p.
Autor:
Hong Luo, Chaohong He, Chuanjun Du, Xiaojian Qin, Shaoxing Zhu, Zhongquan Sun, Weiqing Han, Qing Zou, Weijie Gu, Tie Chong, Ben Wan, Dingwei Ye, Xin Yao
Publikováno v:
Journal of Clinical Oncology. 38:90-90
90 Background: SHR3680 is a novel and pure androgen-receptor (AR) antagonist that shows a potent antitumor activity against CRPC but with much less brain distribution than enzalutamide in preclinical study. In this first-in-human phase 1/2 study, the
Autor:
Hua Wang, Yipeng Xu, Zhijian Cai, Gu Zhang, Shaoxing Zhu, Ying Su, Fei Yang, Yue-Hong Shen, An Zhao
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 1, p e0147173 (2016)
PLoS ONE, Vol 11, Iss 1, p e0147173 (2016)
CAR is a transmembrane protein that is expressed in various epithelial and endothelial cells. CAR mediates adenoviral infection, as well as adenovirus-mediated oncolysis of AxdAdB-3, an E1A/E1B double-restricted oncolytic adenovirus, in prostate canc
Autor:
Shaoxing Zhu, Yipeng Xu
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 35(2)
Angiogenesis is crucial for the development and metastasis of common cancers, and vascular endothelial growth factor (VEGF) is a key mediator in the process of angiogenesis. Numerous studies assessed the associations of VEGF 1154G/A and 2578C/A polym